Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Short Term Economic Evaluation of the Digital Platform Support, Monitoring And Reminder Technology for Mild Dementia (SMART4MD) for People with Mild Cognitive Impairment and Their Informal Caregivers

Ghani, Zartashia LU ; Saha, Sanjib LU ; Jarl, Johan LU orcid ; Andersson, Martin ; Berglund, Johan Sanmartin LU and Anderberg, Peter LU (2022) In Journal of Alzheimer's disease : JAD 86(4). p.1629-1641
Abstract

BACKGROUND: A randomized controlled trial of the SMART4MD tablet application was conducted for persons with mild cognitive impairment (PwMCI) and their informal caregivers to improve or maintain quality of life.

OBJECTIVE: The objective was to conduct economic evaluation of SMART4MD compared to standard care in Sweden from a healthcare provider perspective based on a 6-month follow-up period.

METHODS: Three hundred forty-five dyads were enrolled: 173 dyads in the intervention group and 172 in standard care. The primary outcome measures for PwMCI and informal caregivers were quality-adjusted life years (QALY). The results are presented as incremental cost-effectiveness ratios, and confidence intervals are calculated using... (More)

BACKGROUND: A randomized controlled trial of the SMART4MD tablet application was conducted for persons with mild cognitive impairment (PwMCI) and their informal caregivers to improve or maintain quality of life.

OBJECTIVE: The objective was to conduct economic evaluation of SMART4MD compared to standard care in Sweden from a healthcare provider perspective based on a 6-month follow-up period.

METHODS: Three hundred forty-five dyads were enrolled: 173 dyads in the intervention group and 172 in standard care. The primary outcome measures for PwMCI and informal caregivers were quality-adjusted life years (QALY). The results are presented as incremental cost-effectiveness ratios, and confidence intervals are calculated using non-parametric bootstrap procedure.

RESULTS: For PwMCI, the mean difference in total costs between intervention and standard care was € 12 (95% CI: -2090 to 2115) (US$ = € 1.19) and the mean QALY change was -0.004 (95% CI: -0.009 to 0.002). For informal caregivers, the cost difference was - € 539 (95% CI: -2624 to 1545) and 0.003 (95% CI: -0.002 to 0.008) for QALY. The difference in cost and QALY for PwMCI and informal caregivers combined was -€ 527 (95% CI: -3621 to 2568) and -0.001 (95% CI: -0.008 to 0.006). Although generally insignificant differences, this indicates that SMART4MD, compared to standard care was: 1) more costly and less effective for PwMCI, 2) less costly and more effective for informal caregivers, and 3) less costly and less effective for PwMCI and informal caregivers combined.

CONCLUSION: The cost-effectiveness of SMART4MD over 6 months is inconclusive, although the intervention might be more beneficial for informal caregivers than PwMCI.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Alzheimer's disease : JAD
volume
86
issue
4
pages
1629 - 1641
publisher
IOS Press
external identifiers
  • pmid:35213366
  • scopus:85129312070
ISSN
1387-2877
DOI
10.3233/JAD-215013
language
English
LU publication?
yes
id
012a795c-4bc7-4f60-93a0-8effd2fde1ad
date added to LUP
2022-03-07 06:43:17
date last changed
2024-06-13 16:51:35
@article{012a795c-4bc7-4f60-93a0-8effd2fde1ad,
  abstract     = {{<p>BACKGROUND: A randomized controlled trial of the SMART4MD tablet application was conducted for persons with mild cognitive impairment (PwMCI) and their informal caregivers to improve or maintain quality of life.</p><p>OBJECTIVE: The objective was to conduct economic evaluation of SMART4MD compared to standard care in Sweden from a healthcare provider perspective based on a 6-month follow-up period.</p><p>METHODS: Three hundred forty-five dyads were enrolled: 173 dyads in the intervention group and 172 in standard care. The primary outcome measures for PwMCI and informal caregivers were quality-adjusted life years (QALY). The results are presented as incremental cost-effectiveness ratios, and confidence intervals are calculated using non-parametric bootstrap procedure.</p><p>RESULTS: For PwMCI, the mean difference in total costs between intervention and standard care was € 12 (95% CI: -2090 to 2115) (US$ = € 1.19) and the mean QALY change was -0.004 (95% CI: -0.009 to 0.002). For informal caregivers, the cost difference was - € 539 (95% CI: -2624 to 1545) and 0.003 (95% CI: -0.002 to 0.008) for QALY. The difference in cost and QALY for PwMCI and informal caregivers combined was -€ 527 (95% CI: -3621 to 2568) and -0.001 (95% CI: -0.008 to 0.006). Although generally insignificant differences, this indicates that SMART4MD, compared to standard care was: 1) more costly and less effective for PwMCI, 2) less costly and more effective for informal caregivers, and 3) less costly and less effective for PwMCI and informal caregivers combined.</p><p>CONCLUSION: The cost-effectiveness of SMART4MD over 6 months is inconclusive, although the intervention might be more beneficial for informal caregivers than PwMCI.</p>}},
  author       = {{Ghani, Zartashia and Saha, Sanjib and Jarl, Johan and Andersson, Martin and Berglund, Johan Sanmartin and Anderberg, Peter}},
  issn         = {{1387-2877}},
  language     = {{eng}},
  month        = {{02}},
  number       = {{4}},
  pages        = {{1629--1641}},
  publisher    = {{IOS Press}},
  series       = {{Journal of Alzheimer's disease : JAD}},
  title        = {{Short Term Economic Evaluation of the Digital Platform Support, Monitoring And Reminder Technology for Mild Dementia (SMART4MD) for People with Mild Cognitive Impairment and Their Informal Caregivers}},
  url          = {{http://dx.doi.org/10.3233/JAD-215013}},
  doi          = {{10.3233/JAD-215013}},
  volume       = {{86}},
  year         = {{2022}},
}